Below is a working bibliography of trusted health, pharmacovigilance, and legal-analysis sources, compiled for open research.
Treatment for severe Merkel cell carcinoma after Avelumab — Background & Analysis
A focused look at the background, context, and key sources on this subject.
Reference: National Institutes of Health (NIH)
Authoritative source for clinical, regulatory, and public-health background reading.
Reference: European Medicines Agency (EMA)
Authoritative source for clinical, regulatory, and public-health background reading.
Reference: PubMed Central (PMC)
Authoritative source for clinical, regulatory, and public-health background reading.